M. Pfaller

发表

Heparin interferes with the radioenzymatic and homogeneous enzyme immunoassays for aminoglycosides.

P. Murray, D. Krogstad, R. Valdes, 1982, Clinical chemistry.

Comparative study of the ability of four aminoglycoside assay techniques to detect the inactivation of aminoglycosides by beta-lactam antibiotics.

P. Murray, R. Valdes, G. G. Granich, 1984, Diagnostic microbiology and infectious disease.

Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay

P. Murray, D. Krogstad, G. G. Granich, 1984, Journal of clinical microbiology.

Molecular epidemiology for local outbreaks of methicillin resistantStaphylococcus aureus (MRSA)

M. Pfaller, M. Pfaller, M. Pedro-Botet, 1994, European Journal of Epidemiology.

"White-opaque transition": a second high-frequency switching system in Candida albicans

D. Soll, M. Staebell, M. Pfaller, 1987, Journal of bacteriology.

Developments in the diagnostic mycology laboratory.

C. de Vroey, E. Guého, G. Roberts, 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

Antioxidant Enzyme Expression in Clinical Isolates of Pseudomonas aeruginosa: Identification of an Atypical Form of Manganese Superoxide Dismutase

D. Hassett, R. Miller, B. Britigan, 2001, Infection and Immunity.

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp

J. Turnidge, D. Diekema, R. Jones, 2009, Journal of Clinical Microbiology.

Restriction endonuclease analysis of plasmid DNA from methicillin-resistant Staphylococcus aureus: clinical application over a three-year period.

R. Wenzel, M. Nettleman, R. Hollis, 1993 .

Susceptibility ofHaemophilus influenzae to clarithromycin alone and in combination with its 14-hydroxy metabolite

A. Barry, P. Fuchs, M. Pfaller, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

Clinical laboratory comparison of a slide blood culture system with a conventional broth system

P. Murray, J. Hoppe-Bauer, M. Pfaller, 1982, Journal of clinical microbiology.

Evaluation of the Kirby-Bauer disc diffusion test as a screening test for high-level aminoglycoside resistance in enterococci.

P. Murray, M. Pfaller, A. Niles, 1984, American journal of clinical pathology.

Multiple Candida strains in the course of a single systemic infection

D. Soll, M. Staebell, J. Hicks, 1988, Journal of clinical microbiology.

Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

M. Castanheira, S. Lockhart, M. Pfaller, 2012, Journal of Clinical Microbiology.

Ampicillin-sulbactam susceptibility testing criteria

D. Hardy, P. Fuchs, M. Pfaller, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Animal and Human Multidrug-Resistant, Cephalosporin-Resistant Salmonella Isolates Expressing a Plasmid-Mediated CMY-2 AmpC b -Lactamase

M. Apley, G. Doern, P. Winokur, 2000 .

In vitro comparison of cefpirome and four other beta-lactam antibiotics alone and in combination with tobramycin against clinical isolates of Pseudomonas aeruginosa.

R. Wenzel, M. Bale, M. Pfaller, 1989, Diagnostic microbiology and infectious disease.

Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis

L. Herwaldt, R. Sesso, R. Hollis, 1990, Journal of clinical microbiology.

Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata

M. Pfaller, A. Houston, M. Pfaller, 1996, Journal of clinical microbiology.

In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method

A. Barry, M. Pfaller, M. Pfaller, 2005, Mycopathologia.

Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis

H. Isenberg, M. Pfaller, M. Branchini, 1994, Journal of clinical microbiology.

Efficacy of microbial identification system for epidemiologic typing of coagulase-negative staphylococci

D. Birnbaum, D. Low, A. Chow, 1994, Journal of clinical microbiology.

Comparison of four DNA-based methods for strain delineation of Candida lusitaniae

S. Moser, W. Merz, M. Pfaller, 1995, Journal of clinical microbiology.

Identification of Candida dubliniensis Based on Temperature and Utilization of Xylose and α-Methyl-d-Glucoside as Determined with the API 20C AUX and Vitek YBC Systems

D. Soll, S. Joly, D. Coleman, 1999, Journal of Clinical Microbiology.

Antifungal Susceptibility Testing of Isolates from a Randomized, Multicenter Trial of Fluconazole versus Amphotericin B as Treatment of Nonneutropenic Patients with Candidemia

J. Rex, P. W. Nelson, A. Barry, 1994 .

Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci

M. Weinstein, J. Hindler, M. Ferraro, 1995, Journal of clinical microbiology.

Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents

R. Wenzel, M. Yu, M. Pfaller, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Exophiala oligosperma Causing Olecranon Bursitis

G. S. de Hoog, A. Grooters, M. Rinaldi, 2003, Journal of Clinical Microbiology.

Susceptibility of clinical isolates of Candida spp. to terconazole and other azole antifungal agents.

M. Pfaller, T. Gerarden, 1989, Diagnostic microbiology and infectious disease.

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993

A. Barry, P. Fuchs, M. Pfaller, 1994, Antimicrobial Agents and Chemotherapy.

Multicenter in vitro evaluation of SM-7338, a new carbapenem

R. Jones, K. Aldridge, A. Barry, 1989, Antimicrobial Agents and Chemotherapy.

Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers

P. Fuchs, M. Pfaller, S. Allen, 1995, Antimicrobial agents and chemotherapy.

In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101

R. Jones, K. Aldridge, A. Barry, 1988, European Journal of Clinical Microbiology and Infectious Diseases.

In Vitro Evaluation of BI 397, a Novel Glycopeptide Antimicrobial Agent

M. Pfaller, R. Jones, D. M. Johnson, 2001, Journal of chemotherapy.

Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.

R. Jones, J. Washington, K. Aldridge, 1988, Diagnostic microbiology and infectious disease.

Standardized susceptibility testing of fluconazole: an international collaborative study

T. Walsh, M. Rinaldi, A. Espinel-Ingroff, 1992, Antimicrobial Agents and Chemotherapy.

Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans

M. Pfaller, M. Pfaller, V. Morthland, 1994, Journal of clinical microbiology.

The use of the Prompt Inoculation System in preparing a standardized yeast inoculum.

M. Pfaller, T. Gerarden, 1987, American Journal of Clinical Pathology.

In vitro antibacterial activity of cefpiramide

P. Murray, M. Pfaller, A. Niles, 1984, Antimicrobial Agents and Chemotherapy.

Activity of Isavuconazole and Comparator Antifungals Tested against Contemporary (2012) Fungal Clinical Isolates Collected Worldwide

M. Castanheira, S. Messer, M. Pfaller, 2013 .

Activity of a Novel Echinocandin Biafungin (CD101) Tested against Most Common Candida and Aspergillus Species, Including Echinocandin- and Azole-resistant Strains

M. Castanheira, S. Messer, M. Pfaller, 2014 .

Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates ofEnterobacteriaceae

D. Hardy, P. Fuchs, M. Pfaller, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam

D. Hardy, A. Barry, P. Fuchs, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Desacetylcefotaxime--another broad spectrum cephalosporin?

L. Ayers, R. Jones, A. Barry, 1989, The Journal of antimicrobial chemotherapy.

Candida zeylanoides: another opportunistic yeast

H. Isenberg, R. Hollis, D. Levenson, 1991, Journal of clinical microbiology.

Comparison of three methods for recovery of yeasts from hands of health-care workers

L. Strausbaugh, M. Pfaller, D. Sewell, 1996, Journal of clinical microbiology.

Impact of the changing epidemiology of fungal infections in the 1990s

R. Wenzel, M. Pfaller, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Clinical laboratory evaluation of a urine screening device

P. Murray, M. Pfaller, C. Baum, 1983, Journal of clinical microbiology.

Value of the cand-tec candida antigen assay in the diagnosis and therapy of systemic candidiasis in High-Risk patients

R. Wenzel, R. Gingrich, F. Koontz, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species.

M. Castanheira, P. Rhomberg, S. Messer, 2015, Diagnostic microbiology and infectious disease.

Genotypic Variation andSlimeProduction among Bloodand Catheter Isolates ofCandida parapsilosis

H. Isenberg, M. Pfaller, M. Branchini, 1994 .

In vitro selection of resistance to vancomycin in bloodstream isolates ofStaphylococcus haemolyticus andStaphylococcus epidermidis

L. Herwaldt, L. Boyken, M. Pfaller, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

Development of a standardized screening method for detection of vancomycin-resistant enterococci

M. Weinstein, M. Ferraro, F. Tenover, 1994, Journal of clinical microbiology.

The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.

M. Pfaller, H. Isenberg, M. Pfaller, 1995, American journal of infection control.

Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains.

R. Jones, K. Aldridge, P. Fuchs, 1989, Diagnostic microbiology and infectious disease.

Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers.

R. Jones, K. Aldridge, P. Fuchs, 1991, Diagnostic microbiology and infectious disease.

Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid

A. Barry, P. Fuchs, M. Pfaller, 1993, Antimicrobial Agents and Chemotherapy.

Hospital Specificity, Region Specificity, and Fluconazole Resistance of Candida albicans Bloodstream Isolates

D. Soll, R. Wenzel, M. Edmond, 1998, Journal of Clinical Microbiology.

High frequency of yeast carriage on hands of hospital personnel

M. Pfaller, L. Strausbaugh, M. Pfaller, 1994, Journal of clinical microbiology.

Comparison ofTryptic SoyBrothwithTryptic SoyBroth Supplemented withSucrose intheSepti-Chek BloodCulture System

P. Murray, M. Pfaller, L. Westfall, 1983 .

In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of Enterobacteriaceae.

D. Hardy, A. Barry, P. Fuchs, 1993, Diagnostic microbiology and infectious disease.

Tryptic Soy Broth with Tryptic

M. Pfaller, A. Niles, L. Westfall, 2022 .

In-vitro activity of five β-lactam/β-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa

D. Hardy, A. Barry, P. Fuchs, 1994 .

Error rates in cefoperazone and cefoperazone-sulbactam disk tests withenterobacteriaceae andPseudomonas aeruginosa

D. Hardy, A. Barry, P. Fuchs, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control.

L. Ayers, R. Jones, A. Barry, 1988, Diagnostic microbiology and infectious disease.

The antibacterial activity of co-amoxiclav.

A. Barry, P. Fuchs, M. Pfaller, 1993, The Journal of antimicrobial chemotherapy.

Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates

A. Barry, P. Fuchs, M. Pfaller, 1991, Antimicrobial Agents and Chemotherapy.

Elucidating the Origins of Nosocomial Infections with Candida albicans by DNA Fingerprinting with the Complex Probe Ca3

L. Saiman, D. Soll, R. Wenzel, 1999, Journal of Clinical Microbiology.

Development and verification of fingerprinting probes for Candida glabrata.

D. Soll, J. Sobel, S. Lockhart, 1997, Microbiology.

Comparison of the Septi-Chek AFB and BACTEC systems and conventional culture for recovery of mycobacteria

A. L. Rashad, M. Pfaller, D. Sewell, 1993, Journal of clinical microbiology.

Value of routine aerobic subculturing of unvented blood culture bottles

P. Murray, M. Pfaller, L. Westfall, 1983, Journal of Clinical Microbiology.

Application of genomic DNA subtyping by pulsed field gel electrophoresis and restriction enzyme analysis of plasmid DNA to characterize methicillin-resistant Staphylococcus aureus from two nosocomial outbreaks.

A. T. Tresoldi, M. Pfaller, M. Pfaller, 1993, Diagnostic microbiology and infectious disease.

Antimicrobial activity and disk diffusion susceptibility testing of Ro 40-6890, the active metabolite of the new cephalosporin ester, Ro 41-3399

A. Barry, P. Fuchs, M. Pfaller, 1993, Antimicrobial Agents and Chemotherapy.

Spontaneously occurring staphylococcal mutants resistant to clinically achievable concentrations of ciprofloxacin and temafloxacin

A. Barry, P. Fuchs, M. Pfaller, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Evaluation of two commercial systems for identification of coagulase-negative staphylococci to species level.

M. Pfaller, D. Sewell, C. Grant, 1994, Diagnostic microbiology and infectious disease.

Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine

F. Tenover, L. Reller, D. Hardy, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Evaluation of disk susceptibility testing of fosfomycin tromethamine.

A. Barry, P. Fuchs, M. Pfaller, 1993, Diagnostic microbiology and infectious disease.

Haemophilus test medium versus Mueller-Hinton broth with lysed horse blood for antimicrobial susceptibility testing of four bacterial species

A. Barry, P. Fuchs, M. Pfaller, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

RO 23-9424, a new cephalosporin 3'-quinolone: in-vitro antimicrobial activity and tentative disc diffusion interpretive criteria.

A. Barry, P. Fuchs, M. Pfaller, 1993, The Journal of antimicrobial chemotherapy.

Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.

M. Pfaller, S. Redding, M. Rinaldi, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In Vitro Activity of Anidulafungin and Voriconazole and Comparators against Aspergillus spp. as Determined by CLSI and EUCAST Broth Microdilution Methods

M. Castanheira, S. Messer, M. Pfaller, 2011 .

Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family Enterobacteriaceae

D. Hardy, A. Barry, P. Fuchs, 1992, Antimicrobial Agents and Chemotherapy.

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

M. Pfaller, D. Diekema, S. Messer, 2009, Journal of Clinical Microbiology.

Collaborative investigation of variables in susceptibility testing of yeasts

J. Galgiani, M. Pfaller, R. Fromtling, 1990, Antimicrobial Agents and Chemotherapy.

Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection

M. Pfaller, S. Redding, S. Messer, 1997, Journal of clinical microbiology.

In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates

M. Pfaller, R. Hollis, M. Pfaller, 1996, Journal of clinical microbiology.

Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam

D. Hardy, A. Barry, P. Fuchs, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.

T. C. White, M. Pfaller, S. Redding, 1997, Oral diseases.

Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.

M. Pfaller, R. Jones, S. Messer, 1998, Diagnostic microbiology and infectious disease.

Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae

M. Pfaller, S. Messer, R. Jones, 1997, Antimicrobial agents and chemotherapy.

Activities of Available and Investigational Antifungal Agents against Rhodotorula Species

M. Pfaller, D. Diekema, S. Messer, 2005, Journal of Clinical Microbiology.